Please login to the form below

Not currently logged in
Email:
Password:

ACP-501

This page shows the latest ACP-501 news and features for those working in and with pharma, biotech and healthcare.

AZ boosts cardiovascular pipeline with US biotech acquisition

AZ boosts cardiovascular pipeline with US biotech acquisition

The deal gives AZ access to AlphaCore's ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. ... Last year a phase I clinical trial of ACP-501 in patients with stable atherosclerosis met the primary safety and tolerability

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...